Seeking Alpha

Snake Road

Snake Road
Send Message
View as an RSS Feed
Latest  |  Highest rated
  • Shares of Amarin (AMRN -4.4%) spike lower after the FDA's latest Orange Book update shows no change in the status of its fish-oil pill Vascepa. M&A speculators had been optimistic on a decision from regulators over the exclusivity of the pill would be coming this month, because last week a draft response letter made the rounds around the FDA which made no mention of 'no decision' this month, as it has previously before. [View news story]
    Novice invester. Could someone please tell me why 90% of todays volume took place after 1:15 PM ET. Optimist that I am I'd like to think that SEC rules require that a possible acquirer of amrn had to divest themselves of shares to get below a certain trigger point between tender offer and hostile takeover. wouldn't that be nice.
    Nov 17, 2012. 06:12 AM | 1 Like Like |Link to Comment
1 Comment
1 Like